Stephen Bourke
Stephen Bourke

Advisor, Strategy and Communications

Stephen co-founded Echo (now LloydsDirect), a digital pharmacy, and helped scale it to over 500,000 active patients across the UK. Echo was acquired by McKesson (NYSE:MCK) in 2021.  He previously launched online doctor services in Ireland and Australia and has over 15 years experience building digital products in healthcare. 

An NHS innovation fellow, Stephen supports Small Pharma with strategy and communications.  

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

With a focus on innovative approaches and committed to challenging the status quo, we’re targeting the root causes of depression and hoping to unlock the minds of millions.

Get Small Pharma updates

    Investor Deck

    Follow us: